Brooks Laboratories Limited
NSE: BROOKS.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Prashant Rathi
- Employees
- 293
- Headquarters
- Mumbai, India
- IPO year
- 2011
- Market cap
- ₹1.5B
- Website
- https://www.brookslabs.net
Loading BROOKS…
Loading profile data…Frequently asked questions about BROOKS
What does Brooks Laboratories Limited (BROOKS.NS) do?
Brooks Laboratories Limited manufactures and sells pharmaceuticals on contract basis in India and internationally. It offers carbapenem drugs; tablets; dry syrup; liquid and dry power injections; and eye and ear drop. Brooks Laboratories Limited was incorporated in 2002 and is based in Mumbai, India.
Where does BROOKS.NS trade?
Brooks Laboratories Limited (BROOKS.NS) trades on the National Stock Exchange of India.
What sector is BROOKS.NS in?
Brooks Laboratories Limited (BROOKS.NS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Brooks Laboratories Limited?
Prashant Rathi is the chief executive officer of Brooks Laboratories Limited (BROOKS.NS).
Where is Brooks Laboratories Limited headquartered?
Brooks Laboratories Limited is headquartered in India.
Does BROOKS.NS pay a dividend?
Brooks Laboratories Limited (BROOKS.NS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BROOKS.NS go public?
Brooks Laboratories Limited (BROOKS.NS) completed its initial public offering in 2011.